Major series in different tumor patients reporting the frequency of each genotype of the MMP-1 promoter
N = | Genotype (% of total number tested) | ||||||
---|---|---|---|---|---|---|---|
G/G | GG/GG | G/GG | |||||
Rutter et al. (15) | Controls | 100 | 31 | 30 | 39 | ||
Tumor cell lines | 8 | 12.5 | 62.5 | 25 | |||
Kanamori et al. (18) | Controls | 150 | 20 | 43 | 37 | ||
Ovarian cancer | 163 | 11 | 37 | 52 | |||
Nishioka et al. (24) | |||||||
Endometrial carcinoma | 100 | 9 | 50 | 41 | |||
Ye et al. (25) | Controls | 142 | 29 | 23 | 48 | ||
Cutaneous malignant melanoma | 139 | 24 | 29 | 47 | |||
Present study | Chondrosarcoma | 67 | 27 | 22 | 51 |